These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26530439)

  • 21. Three-dimensional culture system identifies a new mode of cetuximab resistance and disease-relevant genes in colorectal cancer.
    Li C; Singh B; Graves-Deal R; Ma H; Starchenko A; Fry WH; Lu Y; Wang Y; Bogatcheva G; Khan MP; Milne GL; Zhao S; Ayers GD; Li N; Hu H; Washington MK; Yeatman TJ; McDonald OG; Liu Q; Coffey RJ
    Proc Natl Acad Sci U S A; 2017 Apr; 114(14):E2852-E2861. PubMed ID: 28320945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance.
    Tak E; Kim M; Cho Y; Choi S; Kim J; Han B; Kim HD; Jang CS; Kim JE; Hong YS; Kim SY; Kim TW
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34779495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pan-cancer analysis reveals an immunological role and prognostic potential of PXN in human cancer.
    Chen Y; Zhao H; Xiao Y; Shen P; Tan L; Zhang S; Liu Q; Gao Z; Zhao J; Zhao Y; Guo Y; Feng Y
    Aging (Albany NY); 2021 Jun; 13(12):16248-16266. PubMed ID: 34135128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Paxillin is Correlated with Clinical Prognosis in Colorectal Cancer Patients.
    Zhao CJ; Du SK; Dang XB; Gong M
    Med Sci Monit; 2015 Jul; 21():1989-95. PubMed ID: 26159303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway.
    Chen LC; Tu SH; Huang CS; Chen CS; Ho CT; Lin HW; Lee CH; Chang HW; Chang CH; Wu CH; Lee WS; Ho YS
    Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.
    Perathoner A; Pirkebner D; Brandacher G; Spizzo G; Stadlmann S; Obrist P; Margreiter R; Amberger A
    Clin Cancer Res; 2005 May; 11(9):3274-9. PubMed ID: 15867223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ZNF703 promotes tumor cell proliferation and invasion and predicts poor prognosis in patients with colorectal cancer.
    Ma F; Bi L; Yang G; Zhang M; Liu C; Zhao Y; Wang Y; Wang J; Bai Y; Zhang Y
    Oncol Rep; 2014 Sep; 32(3):1071-7. PubMed ID: 25017610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.
    Troiani T; Martinelli E; Napolitano S; Vitagliano D; Ciuffreda LP; Costantino S; Morgillo F; Capasso A; Sforza V; Nappi A; De Palma R; D'Aiuto E; Berrino L; Bianco R; Ciardiello F
    Clin Cancer Res; 2013 Dec; 19(24):6751-65. PubMed ID: 24122793
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.
    de Heer P; Koudijs MM; van de Velde CJ; Aalbers RI; Tollenaar RA; Putter H; Morreau J; van de Water B; Kuppen PJ
    Eur J Surg Oncol; 2008 Nov; 34(11):1253-61. PubMed ID: 18556171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Paxillin genes and actomyosin contractility regulate myotome morphogenesis in zebrafish.
    Jacob AE; Amack JD; Turner CE
    Dev Biol; 2017 May; 425(1):70-84. PubMed ID: 28315297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.
    Rosa R; Marciano R; Malapelle U; Formisano L; Nappi L; D'Amato C; D'Amato V; Damiano V; Marfè G; Del Vecchio S; Zannetti A; Greco A; De Stefano A; Carlomagno C; Veneziani BM; Troncone G; De Placido S; Bianco R
    Clin Cancer Res; 2013 Jan; 19(1):138-47. PubMed ID: 23166225
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paxillin mutations affect focal adhesions and lead to altered mitochondrial dynamics: relevance to lung cancer.
    Kawada I; Hasina R; Lennon FE; Bindokas VP; Usatyuk P; Tan YH; Krishnaswamy S; Arif Q; Carey G; Hseu RD; Robinson M; Tretiakova M; Brand TM; Iida M; Ferguson MK; Wheeler DL; Husain AN; Natarajan V; Vokes EE; Singleton PA; Salgia R
    Cancer Biol Ther; 2013 Jul; 14(7):679-91. PubMed ID: 23792636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. No somatic genetic change in the paxillin gene in nonsmall-cell lung cancer.
    Pallier K; Houllier AM; Le Corre D; Cazes A; Laurent-Puig P; Blons H
    Mol Carcinog; 2009 Jul; 48(7):581-5. PubMed ID: 19353596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer.
    Chu XY; Zhu ZM; Chen LB; Wang JH; Su QS; Yang JR; Lin Y; Xue LJ; Liu XB; Mo XB
    Acta Histochem; 2012 Dec; 114(8):755-62. PubMed ID: 22326401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer-related CD15/FUT4 overexpression decreases benefit to agents targeting EGFR or VEGF acting as a novel RAF-MEK-ERK kinase downstream regulator in metastatic colorectal cancer.
    Giordano G; Febbraro A; Tomaselli E; Sarnicola ML; Parcesepe P; Parente D; Forte N; Fabozzi A; Remo A; Bonetti A; Manfrin E; Ghasemi S; Ceccarelli M; Cerulo L; Bazzoni F; Pancione M
    J Exp Clin Cancer Res; 2015 Oct; 34():108. PubMed ID: 26427914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally.
    Wang Y; Ding X; Liu B; Li M; Chang Y; Shen H; Xie SM; Xing L; Li Y
    Mol Carcinog; 2020 Jan; 59(1):73-86. PubMed ID: 31670855
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combinational treatment with microRNA‑133b and cetuximab has increased inhibitory effects on the growth and invasion of colorectal cancer cells by regulating EGFR.
    Zhou J; Lv L; Lin C; Hu G; Guo Y; Wu M; Tian B; Li X
    Mol Med Rep; 2015 Oct; 12(4):5407-14. PubMed ID: 26151111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer.
    Huang F; Zhao Y; Zhao J; Wu S; Jiang Y; Ma H; Zhang T
    Int J Clin Exp Pathol; 2014; 7(9):6006-14. PubMed ID: 25337245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.
    Di Nicolantonio F; Martini M; Molinari F; Sartore-Bianchi A; Arena S; Saletti P; De Dosso S; Mazzucchelli L; Frattini M; Siena S; Bardelli A
    J Clin Oncol; 2008 Dec; 26(35):5705-12. PubMed ID: 19001320
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and biological significance of miR-378a-3p and miR-378a-5p in colorectal cancer.
    Li H; Dai S; Zhen T; Shi H; Zhang F; Yang Y; Kang L; Liang Y; Han A
    Eur J Cancer; 2014 Apr; 50(6):1207-21. PubMed ID: 24412052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.